HIV-associated lymphoma: Promising new results, but with toxicity

Blood

Volumn 105, Issue 5, 2005, Pages 1842-

  Straus, David J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

B CELL LYMPHOMA; BONE MARROW; CHEMOTHERAPY; CLINICAL TRIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTION; INFECTION RATE; MORTALITY; PRIORITY JOURNAL; REMISSION; REVIEW; SURVIVAL RATE; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; DRUG TOXICITY; NOTE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG TOXICITY; ETOPOSIDE; HUMANS; INFECTION; LYMPHOMA, AIDS-RELATED;

EID: 21144442257     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-12-4729     Document Type: Review

References (5)

1. Kaplan LD, Straus DJ, Testa MA, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immuno-deficiency virus infection: National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group, N Engl J Med. 1997;336:1641-1648.
2. Sparano JA, Weiler E, Nazeer T, et al. Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgrkin lympboma: an Eastern Cooperative Oncology Group trial (E3493). Blood. 2002;100:1634-1640.
3. Coiffier B, Lepage E, Briere J, et al. CHOP chemo-therapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engt J Med. 2002;346:235-242.
4. Kaplan LD, Scadden DT. No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximab for patients with HIV-associated non-Hodgkin's lymphoma: AIDS Malginancy Consortium Study 010 [abstract]. Proc Am Soc Clin Oncol. 2003;22:564.
5. Little RF, Pittaluga S, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood. 2003; 101:4653-4659.